Would the liability of Brazilian litigation funders be at risk?
9/30/2021 A recent decision from the English Court of Appeal, rendered in the ChapelGate[1] case, upheld the High Court of Justice determination regarding the litigation funder’s liability, which was, in terms of costs to the prevailing party, not limited to the financed amount. The judgment shed light on the application of another local precedent, known […]
The Supreme Court decides that IRPJ and CSLL shall not be levied on amounts received of SELIC rate on refund of undue tax payments
9/30/2021 On September 27, 2021, the Brazilian Supreme Court (STF) decided that Corporate Income Tax (IRPJ) and Social Contribution on Net Income (CSLL) shall not be levied on interests (SELIC rate) from the refund of undue tax overpayments. In the judgment prevailed Dias Toffoli Minister’s understanding that the SELIC rate is an indemnity for the […]
Decision exempts fine from store that ended its activities during the pandemic
10/6/2021 In a lawsuit filed against a shopping mall, a travel and tourism company claims exemption from the payment of amounts established in the contract between the store and the mall. The request for exemption from payment of contractual fine and condominium was justified by the effects of the Covid-19 pandemic, which stopped its activities. […]
Recentes alterações legislativas no Direito Societário
6/10/2021 Em agosto de 2021 entraram em vigor a Lei nº 14.195 de 26/08/2021 (“Lei nº 14.195/21”) e a Lei Complementar nº 182/2021 (“LC 182/21”), as quais visam, entre outros temas, alterar procedimentos burocráticos e, ainda, regras importantes do Direito Societário. A Lei nº 14.195/21 trouxe, assim, importantes alterações, tais como: Passou a permitir a […]
Anvisa simplifica procedimento de importação de Imunoglobulina Humana
20/9/2021 No último dia 16 de setembro, a Agência Nacional de Vigilância Sanitária publicou a Resolução da Diretoria Colegiada – RDC nº 563 de 15/09/2021, que dispõe, de forma extraordinária e temporária, sobre os requisitos para a importação e uso de imunoglobulina humana, devido a emergência de saúde pública internacional relacionada ao SARS-CoV-2. A adoção da […]
CVM intends to innovate rules for Autonomous Investment Agents and other intermediaries
8/30/2021 The Securities and Exchange Commission (CVM) has developed several mechanisms to offer more predictability, objectivity and efficiency to the Brazilian capital market, aiming at simplifying procedures to attract all kinds of investors. One of these mechanisms is carrying out several public hearings so that CVM can understand the market’s cravings to formulate more practical […]
